# Adult Accuracy Study of the Enlite 3 Glucose Sensor

Study · id `cardio:ct-nct02246582` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02246582](<https://clinicaltrials.gov/study/NCT02246582>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02246582

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 118 participants.

## Technical summary

Registry record NCT02246582. Randomized; no masking. Start 2014-09 (registry gives no type); primary completion 2015-08 (actual). Results posted on 2016-11-02.

## Key facts

- Design: Interventional study; randomized; no masking
- Phase: Not applicable
- Enrolled: 118 participants (enrolled count; ClinicalTrials.gov record NCT02246582, source copy `cardio:ctgov-nct02246582-2016-11-02`, retrieved 2026-10-26)
- Start date: 2014-09 (registry gives no type) (ClinicalTrials.gov record NCT02246582, source copy `cardio:ctgov-nct02246582-2016-11-02`, retrieved 2026-10-26)
- Primary completion: 2015-08 (actual) (ClinicalTrials.gov record NCT02246582, source copy `cardio:ctgov-nct02246582-2016-11-02`, retrieved 2026-10-26)
- Completion: 2015-08 (actual) (ClinicalTrials.gov record NCT02246582, source copy `cardio:ctgov-nct02246582-2016-11-02`, retrieved 2026-10-26)
- Results first posted: 2016-11-02 (ClinicalTrials.gov record NCT02246582, source copy `cardio:ctgov-nct02246582-2016-11-02`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02246582, source copy `cardio:ctgov-nct02246582-2016-11-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02246582-2016-11-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Adult Accuracy Study of the Enlite 3 Glucose Sensor
- Acronym: E3
- Condition: Type 1 Diabetes
- Condition: Type 2 Diabetes
- Intervention (Device): Enlite 3
- Intervention (Device): Guardian Mobile App
- Intervention (Device): 640G Insulin Pump
- Lead sponsor: Medtronic MiniMed, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Medtronic MiniMed, Inc. (`cardio:org-medtronic-minimed-inc`)

## Provenance

Content hash: b1ded342edba1583e112e57830db30a51f1c0fdce486142ad73fa9d5bd78245b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
